/
Making skin health accessible for all: unveiling the challenges in diagnosing skin conditions on darker skin
The role of myGP in the battle against Covid-19
April 9, 2020
The skin is the largest organ of the human body and acts as a protective barrier between the external environment and the inside of the body, shielding the internal organs against heat, light, injury and infection. Yet, the journey to diagnose skin conditions, especially on darker skin tones, can be challenging and not well mapped. In a recent study, physicians were presented with 364 images spanning 46 skin diseases and asked to submit up to four differential diagnoses. The physicians were four percentage points less accurate for the diagnosis of images of dark skin as compared to light skin.
Inherent biases deeply rooted in medical research, literature, and education have led to a healthcare landscape skewed towards lighter skin, often leaving behind those with darker complexions. Doctors diagnose around one-quarter of melanoma cases in Black people when cancer has already spread to nearby lymph nodes. However, amidst these challenges, there are technological advancements, such as AI, that are helping to rectify this imbalance. In May 2024, Autoderm conducted a total of 18,359 analyses through the myGP app and identified 79 cases of melanoma. This equates to about 2-3 melanoma diagnoses per day. Given that approximately 46 melanomas are diagnosed daily across the UK, the cases detected via the myGP app represent about 5% of the total daily melanoma diagnoses in the UK population.
We recognise the need for equitable healthcare solutions for all. Through our partnership with Autoderm, launched in 2023 after years of clinical and AI research, are proud to offer their next generation skin scanner to our community of 3 million users via the myGP app.
The bias in dermatology towards lighter skin tones is a well-documented issue. From medical textbooks to research studies, most visual references and diagnostic criteria are based on observations of mainly fair-skinned individuals.This bias perpetuates a cycle of misdiagnosis and inadequate treatment for patients with darker skin, which can lead to unnecessary distress and prolonged health issues such as increased itching, dryness, skin thickening and hyperpigmentation.
Autoderm and the myGP app, however, are changing the game! By harnessing the power of AI, Autoderm helps improve diagnostic accuracy of skin conditions across all skin tones. Their approach analyses a diverse search engine of skin images (2 million+), encompassing various ethnicities and skin tones. Their algorithm is constantly evolving and learning along with their growing bank of images. Irrespective of skin tone, myGP users can use the tech to get likely answers quickly, easily and choose how to act on the insight.
© 2026 iPLATO. All rights reserved
/
Making skin health accessible for all: unveiling the challenges in diagnosing skin conditions on darker skin
The role of myGP in the battle against Covid-19
April 9, 2020
The skin is the largest organ of the human body and acts as a protective barrier between the external environment and the inside of the body, shielding the internal organs against heat, light, injury and infection. Yet, the journey to diagnose skin conditions, especially on darker skin tones, can be challenging and not well mapped. In a recent study, physicians were presented with 364 images spanning 46 skin diseases and asked to submit up to four differential diagnoses. The physicians were four percentage points less accurate for the diagnosis of images of dark skin as compared to light skin.
Inherent biases deeply rooted in medical research, literature, and education have led to a healthcare landscape skewed towards lighter skin, often leaving behind those with darker complexions. Doctors diagnose around one-quarter of melanoma cases in Black people when cancer has already spread to nearby lymph nodes. However, amidst these challenges, there are technological advancements, such as AI, that are helping to rectify this imbalance. In May 2024, Autoderm conducted a total of 18,359 analyses through the myGP app and identified 79 cases of melanoma. This equates to about 2-3 melanoma diagnoses per day. Given that approximately 46 melanomas are diagnosed daily across the UK, the cases detected via the myGP app represent about 5% of the total daily melanoma diagnoses in the UK population.
We recognise the need for equitable healthcare solutions for all. Through our partnership with Autoderm, launched in 2023 after years of clinical and AI research, are proud to offer their next generation skin scanner to our community of 3 million users via the myGP app.
The bias in dermatology towards lighter skin tones is a well-documented issue. From medical textbooks to research studies, most visual references and diagnostic criteria are based on observations of mainly fair-skinned individuals.This bias perpetuates a cycle of misdiagnosis and inadequate treatment for patients with darker skin, which can lead to unnecessary distress and prolonged health issues such as increased itching, dryness, skin thickening and hyperpigmentation.
Autoderm and the myGP app, however, are changing the game! By harnessing the power of AI, Autoderm helps improve diagnostic accuracy of skin conditions across all skin tones. Their approach analyses a diverse search engine of skin images (2 million+), encompassing various ethnicities and skin tones. Their algorithm is constantly evolving and learning along with their growing bank of images. Irrespective of skin tone, myGP users can use the tech to get likely answers quickly, easily and choose how to act on the insight.
© 2026 iPLATO. All rights reserved

The role of myGP in the battle against Covid-19
April 9, 2020
Today, we are proud that over 1.6 million people trust myGP® to simplify their access to healthcare. Especially at a time of pandemic, it is a hugely important role which we are proud to achieve, while recognising that as we manage critical technology, others put their lives at risk serving in the frontline. We thank doctors, nurses and other colleagues for their effort, determination and brilliance.
First, we can help you access correct information about the virus, its symptoms and spread. There is a huge number of rumours and speculative theories swirling around at this time of crisis. On myGP you will only find information from reliable sources including Public Health England and the NHS. From this week, myGP will offer access to Covid-19 symptom checker and a link through to the Public Health England dashboard regarding local case numbers.
Second, we can help you access the services of your own GP from self-isolation. In a recent development we equipped 2,000 medical professionals with the ability to review your request for care and, then, to message you or conduct a video consultation – all within myGP. We can get a new practice connected in a few days and more doctors are constantly joining the myGP service.
myGP members ordered over 315,000 medicines on myGP in March – the vast majority for ‘click-and-collect’ from their favourite community pharmacy. Over the last few months, we have also been trialling medicines home delivery to ensure that you do not have to go out of your way to collect your medication. The results were clear, and that having a delivery option met the needs of our members in terms of user experience and patient choice, but we must also ensure that home delivery complements the incredible work done by high street pharmacists. We celebrate community pharmacy and we do not wish to destabilise it.
To simplify access to healthcare beyond primary care (GPs and Pharmacy) we partner with a range of specialist providers whose services you can access on myGP. We are fully committed to the NHS ethos of free at the point of care so the services that you can access depend on local NHS funding and, therefore, on where you live. Right now, we offer mental health support and other referal services on myGP with more partners being added all the time thanks to the popularity of the app.
Finally, we can help your doctors look after their most vulnerable patients. In another recent development, we have added tools for your GP to offer selected patients the ability to monitor key vital signs for Covid-19 (temperature, pulse, respiratory rate and oxygen saturation) and feed this important information back to them for review and, then, streamlined filing into their IT systems. This will help them take better care of people who are at elevated risk.
Responding to member needs and constraints imposed by the virus, myGP is moving in the direction of home delivery of healthcare. It seems to work. Fuelled by proactive patient engagement, medicines orders and remote consultation we were humbled to see transaction volumes on the myGP platform increase from 12 million in February to 27 million in March.
All of these services are free to myGP members and available to use by your GP surgery.
We hope to continue to help our members and NHS partners through this crisis and play our important role in simplifying access to healthcare.
Hope to see you soon on myGP!
Regards,
Tobias, CEO at iPLATO Healthcare
© 2026 iPLATO. All rights reserved